A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo.
about
Generalized immune activation as a direct result of activated CD4+ T cell killingModeling the within-host dynamics of HIV infectionHIV evolution in early infection: selection pressures, patterns of insertion and deletion, and the impact of APOBECGenetic draft and quasi-neutrality in large facultatively sexual populationsResidual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cellsCerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatmentInefficient cytotoxic T lymphocyte-mediated killing of HIV-1-infected cells in vivoQuantification of viral infection dynamics in animal experimentsSingle-Cell and Single-Cycle Analysis of HIV-1 ReplicationRates of CTL killing in persistent viral infection in vivoLarge Variations in HIV-1 Viral Load Explained by Shifting-Mosaic Metapopulation DynamicsWhy are there different dynamics in the selection of drug resistance in HIV and hepatitis B and C viruses?Illustration of a measure to combine viral suppression and viral rebound in studies of HIV therapyViral and latent reservoir persistence in HIV-1-infected patients on therapyDrug-class specific impact of antivirals on the reproductive capacity of HIVTreatment-mediated alterations in HIV fitness preserve CD4+ T cell counts but have minimal effects on viral loadHIV quasispecies dynamics during pro-active treatment switching: impact on multi-drug resistance and resistance archiving in latent reservoirsA stochastic model of latently infected cell reactivation and viral blip generation in treated HIV patientsPharmacokinetics and pharmacodynamics of the reverse transcriptase inhibitor tenofovir and prophylactic efficacy against HIV-1 infectionHIV model parameter estimates from interruption trial data including drug efficacy and reservoir dynamicsExplaining the determinants of first phase HIV decay dynamics through the effects of stage-dependent drug actionEstimating HIV-1 fitness characteristics from cross-sectional genotype dataOptimal Treatment Strategies in the Context of 'Treatment for Prevention' against HIV-1 in Resource-Poor SettingsModeling the Slow CD4+ T Cell Decline in HIV-Infected IndividualsResidual Viremia in Treated HIV+ IndividualsModeling the Effects of Morphine on Simian Immunodeficiency Virus DynamicsMolecular clock of HIV-1 envelope genes under early immune selectionIdentification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection[HIV-1 diversity: a tool for studying the pandemic].Evolutionary dynamics of HIV at multiple spatial and temporal scales.Improving the estimation of the death rate of infected cells from time course data during the acute phase of virus infections: application to acute HIV-1 infection in a humanized mouse model.Why don't CD8+ T cells reduce the lifespan of SIV-infected cells in vivo?Multiple polyexponentials and quasipolynomials as empirical nonlinear regression models: a case study with HIV viral load data.Modeling latently infected cell activation: viral and latent reservoir persistence, and viral blips in HIV-infected patients on potent therapy.Mathematical modeling of ultradeep sequencing data reveals that acute CD8+ T-lymphocyte responses exert strong selective pressure in simian immunodeficiency virus-infected macaques but still fail to clear founder epitope sequencesHigh Multiplicity Infection by HIV-1 in Men Who Have Sex with Men.Within-Epitope Interactions Can Bias CTL Escape Estimation in Early HIV InfectionSimilarity in viral and host promoters couples viral reactivation with host cell migrationTemporal analysis of HIV envelope sequence evolution and antibody escape in a subtype A-infected individual with a broad neutralizing antibody responseHIV-1 Populations in Semen Arise through Multiple Mechanisms.
P2860
Q21146758-CDD6D290-F227-42CC-80B6-A9FB9290C686Q21245370-6615F223-3FA7-47A6-909B-A722CB515905Q21559422-C50D9D99-080D-4167-B389-C3FABA98DDB1Q22065128-6600F3E8-204A-4CFB-B3B7-8397835313E6Q24548940-A81962BA-3105-44EA-9BAD-964E6DAC53D4Q24814874-87F0BB65-3312-4D2D-9F35-F8A0CEAF2EEBQ25255777-3B94C01F-EF5D-44B6-86CD-B8E55E9C2D98Q26824804-A8FFEA1B-1BC0-4DB1-99B4-CA99D0C5331EQ27319151-EE2C2BFD-FC43-46F7-8F2C-FFD0B3610832Q27322823-A54FCDA7-D026-4987-A499-486FE0C85F50Q27339956-A46BFDE7-665E-4EC4-8CA6-8C6A6069ACF4Q27487167-FF959D4E-2E7B-4F37-B461-7CF772206492Q28385909-5AF23BC0-2F94-45D8-A39A-D32BDB3A6898Q28469057-313DC133-6639-46FA-8FA5-6661E62C734EQ28473451-E619CC40-5B39-46A1-B44C-2A83280DAA97Q28476227-D2B14A99-4A77-48A5-9D4A-849222DB99DCQ28477500-50E15B6B-D813-44F1-9108-2583A934E96DQ28477926-CD7C7635-811E-44FA-8380-92721C18904FQ28481276-F4040A21-4A25-435B-8D57-948E9020873BQ28481343-3F5EAFB7-1AAD-4C61-9A7F-CB1FA9643EE6Q28489076-9A729C30-5795-418A-9E58-566D7E009DD2Q28544753-EC1C7525-4A4D-4517-9E67-7579920EA7B2Q28547109-344411B9-F54C-4BD0-A722-5479B48D34AEQ28551803-7C26EEB6-B669-44F1-A969-7A957E59F020Q28552126-A9A4BD60-54E1-4218-A6A4-5EA11EA2345BQ28554352-8A133503-B807-4346-A82C-8D2A24829C3EQ28601925-E81B4B3D-F9C2-4EFB-820C-EF4EC2A38BEBQ29619510-10AB0D36-03B5-4F9E-994D-E792F9C6D1E6Q30353625-FE7ADC96-2E2D-47DD-9606-2CE3153B12A5Q30416280-49512243-0936-4CD6-87A7-2FB174773986Q30828221-84DF3E5D-5410-4B3C-8309-975090E9DE7FQ31032227-C91A3B13-F1AE-483A-8F07-FE990634FC76Q33238472-D1ED2F7B-DBF5-46A5-8343-A4E184EAD17EQ33510903-D63B8F59-803A-4282-B40B-F60001CDC992Q33545560-99B21F5C-2456-4918-A09A-D0D8C44AFE9BQ33582135-F091C078-02F0-45A4-AF8F-24D51B3FE06BQ33619649-034F16FB-A0CE-49E0-B917-4890E1D0E905Q33640033-039F9963-407F-4685-9699-0A0D74740513Q33664910-4F799A81-45EE-4EB4-88A8-622B554D2548Q33680752-93F08AA0-38FE-495C-BF98-8FD280A48352
P2860
A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
A novel antiviral intervention ...... mics and T-cell decay in vivo.
@ast
A novel antiviral intervention ...... mics and T-cell decay in vivo.
@en
A novel antiviral intervention ...... mics and T-cell decay in vivo.
@nl
type
label
A novel antiviral intervention ...... mics and T-cell decay in vivo.
@ast
A novel antiviral intervention ...... mics and T-cell decay in vivo.
@en
A novel antiviral intervention ...... mics and T-cell decay in vivo.
@nl
prefLabel
A novel antiviral intervention ...... mics and T-cell decay in vivo.
@ast
A novel antiviral intervention ...... mics and T-cell decay in vivo.
@en
A novel antiviral intervention ...... mics and T-cell decay in vivo.
@nl
P2093
P2860
P1433
P1476
A novel antiviral intervention ...... mics and T-cell decay in vivo.
@en
P2093
Arlene Hurley
David D Ho
Eugene Sun
Martin Markowitz
Michael Louie
Michele Di Mascio
P2860
P304
P356
10.1128/JVI.77.8.5037-5038.2003
P407
P577
2003-04-01T00:00:00Z